Global Drug Discovery Services

Drug Discovery Services Comprehensive Study by Type (Medicinal Chemistry Services, Biology Services, Drug Metabolism and Pharmacokinetics (DMPK), Market, by Drug Type, Small- molecule Drugs, Biologic Drugs), Application (New Drugs Discoveries, Research Studies, Clinical Trials), Company (Tier 1 Pharmaceutical Companies, Tier 2 Pharmaceutical Companies, Tier 3 Pharmaceutical Companies), Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization), Therapeutic Area (Oncology, Neurology, Infectious and Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Other Therapeutic Areas) Players and Region - Global Market Outlook to 2028

Drug Discovery Services Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Drug discovery services facilitate new drugs for human health, for various purposes such as prevention cure, diagnostic and treatment of disease. The new drug discovery is a very long and complicated process but if it gets approval it will be helpful for many incurable diseases. The clinical trials are one of the vital parts of drug discovery services. Various companies are in the market that provides effective drug discovery services on a large scale. Drugs on different therapeutic areas are highly demanded from the last few decades. The stringent FDA guidelines also play a vital role in these services.This growth is primarily driven by Growing Incurable Disorders .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitK Units
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Thermo Fisher Scientific (United States), Albany Molecular Research (United States), Charles River Laboratories International (United States), Evotec SE (Germany), Eurofins Scientific (Luxembourg), WuXi AppTec (China), GenScript Biotech Corporation (China), Jubilant Life Sciences (India), Laboratory Corporation of America Holdings (United States), Piramal Enterprises (India), Viva Biotech (China), Domainex (United Kingdom) and Shanghai Medicilon(China), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In Dec , 2021 Thermo Fisher Scientific Inc. , the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. , a leading global provider of clinical research services to the biopharma and biotech industry,
In Dec. 2023 Merck, a leading science and technology company, today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through SynthiaTM retrosynthesis software application programing interface (API) integrationThe growing drug discoveries are one of the reasons for increasing competition between top leading firms. The research and development department needs to be strong if the company has to launch a new drug in the market. The collaborations and acquisitions are also on fire to catch the market for earning more profit and earnings.

Regulatory Insights:
US FDA has the primary goal to protect public health by regulation and guidelines for food as well as drugs, devices, cosmetics, researches. The FDA regulates through the FDCA, the Code of Federal Regulations and publications in the Federal Register, and by issuing guidance and other regulatory documents. The FDA provides all the required guidelines, documents for new drug discoveries that analyze the critical pathway needed to bring therapeutic products to completion.

Influencing Trend:
Increasing No. of Firms That are Entering into Drug Discoveries

Market Growth Drivers:
Growing Incurable Disorders and Specialty Drugs Discoveries are Highly Demanded

Challenges:
A Long and Complicated Process and Expensive and Heavy Investments Required from the Initial Stage

Restraints:
Regulatory Bodies Have Stringent Rules And Regulations and Man Force is Not Available for Clinical Trials

Opportunities:
Growing Technological Enhancements and A Large No. of Research and Technical Knowledgeable Professionals are Available Worldwide

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Drug Discovery Services Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Drug Discovery Services Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Drug Discovery Services players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Drug Discovery Services Study Sheds Light on
— The Drug Discovery Services Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Drug Discovery Services industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Drug Discovery Services industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Medicinal Chemistry Services
  • Biology Services
  • Drug Metabolism and Pharmacokinetics (DMPK)
  • Market, by Drug Type
  • Small- molecule Drugs
  • Biologic Drugs
By Application
  • New Drugs Discoveries
  • Research Studies
  • Clinical Trials
By Company
  • Tier 1 Pharmaceutical Companies
  • Tier 2 Pharmaceutical Companies
  • Tier 3 Pharmaceutical Companies

By Process
  • Target Selection
  • Target Validation
  • Hit-To-Lead Identification
  • Lead Optimization

By Therapeutic Area
  • Oncology
  • Neurology
  • Infectious and Immune System Diseases
  • Digestive System Diseases
  • Cardiovascular Diseases
  • Other Therapeutic Areas

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Incurable Disorders
      • 3.2.2. Specialty Drugs Discoveries are Highly Demanded
    • 3.3. Market Challenges
      • 3.3.1. A Long and Complicated Process
      • 3.3.2. Expensive and Heavy Investments Required from the Initial Stage
    • 3.4. Market Trends
      • 3.4.1. Increasing No. of Firms That are Entering into Drug Discoveries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Discovery Services, by Type, Application, Company , Process, Therapeutic Area and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Drug Discovery Services (Value)
      • 5.2.1. Global Drug Discovery Services by: Type (Value)
        • 5.2.1.1. Medicinal Chemistry Services
        • 5.2.1.2. Biology Services
        • 5.2.1.3. Drug Metabolism and Pharmacokinetics (DMPK)
        • 5.2.1.4. Market, by Drug Type
        • 5.2.1.5. Small- molecule Drugs
        • 5.2.1.6. Biologic Drugs
      • 5.2.2. Global Drug Discovery Services by: Application (Value)
        • 5.2.2.1. New Drugs Discoveries
        • 5.2.2.2. Research Studies
        • 5.2.2.3. Clinical Trials
      • 5.2.3. Global Drug Discovery Services by: Process (Value)
        • 5.2.3.1. Target Selection
        • 5.2.3.2. Target Validation
        • 5.2.3.3. Hit-To-Lead Identification
        • 5.2.3.4. Lead Optimization
      • 5.2.4. Global Drug Discovery Services by: Therapeutic Area (Value)
        • 5.2.4.1. Oncology
        • 5.2.4.2. Neurology
        • 5.2.4.3. Infectious and Immune System Diseases
        • 5.2.4.4. Digestive System Diseases
        • 5.2.4.5. Cardiovascular Diseases
        • 5.2.4.6. Other Therapeutic Areas
      • 5.2.5. Global Drug Discovery Services Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Drug Discovery Services (Volume)
      • 5.3.1. Global Drug Discovery Services by: Type (Volume)
        • 5.3.1.1. Medicinal Chemistry Services
        • 5.3.1.2. Biology Services
        • 5.3.1.3. Drug Metabolism and Pharmacokinetics (DMPK)
        • 5.3.1.4. Market, by Drug Type
        • 5.3.1.5. Small- molecule Drugs
        • 5.3.1.6. Biologic Drugs
      • 5.3.2. Global Drug Discovery Services by: Application (Volume)
        • 5.3.2.1. New Drugs Discoveries
        • 5.3.2.2. Research Studies
        • 5.3.2.3. Clinical Trials
      • 5.3.3. Global Drug Discovery Services by: Process (Volume)
        • 5.3.3.1. Target Selection
        • 5.3.3.2. Target Validation
        • 5.3.3.3. Hit-To-Lead Identification
        • 5.3.3.4. Lead Optimization
      • 5.3.4. Global Drug Discovery Services by: Therapeutic Area (Volume)
        • 5.3.4.1. Oncology
        • 5.3.4.2. Neurology
        • 5.3.4.3. Infectious and Immune System Diseases
        • 5.3.4.4. Digestive System Diseases
        • 5.3.4.5. Cardiovascular Diseases
        • 5.3.4.6. Other Therapeutic Areas
      • 5.3.5. Global Drug Discovery Services Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Drug Discovery Services (Price)
      • 5.4.1. Global Drug Discovery Services by: Type (Price)
  • 6. Drug Discovery Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Albany Molecular Research (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Charles River Laboratories International (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Evotec SE (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Eurofins Scientific (Luxembourg)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. WuXi AppTec (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GenScript Biotech Corporation (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Jubilant Life Sciences (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Laboratory Corporation of America Holdings (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Piramal Enterprises (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Viva Biotech (China)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Domainex (United Kingdom)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Shanghai Medicilon(China)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Drug Discovery Services Sale, by Type, Application, Company , Process, Therapeutic Area and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Drug Discovery Services (Value)
      • 7.2.1. Global Drug Discovery Services by: Type (Value)
        • 7.2.1.1. Medicinal Chemistry Services
        • 7.2.1.2. Biology Services
        • 7.2.1.3. Drug Metabolism and Pharmacokinetics (DMPK)
        • 7.2.1.4. Market, by Drug Type
        • 7.2.1.5. Small- molecule Drugs
        • 7.2.1.6. Biologic Drugs
      • 7.2.2. Global Drug Discovery Services by: Application (Value)
        • 7.2.2.1. New Drugs Discoveries
        • 7.2.2.2. Research Studies
        • 7.2.2.3. Clinical Trials
      • 7.2.3. Global Drug Discovery Services by: Process (Value)
        • 7.2.3.1. Target Selection
        • 7.2.3.2. Target Validation
        • 7.2.3.3. Hit-To-Lead Identification
        • 7.2.3.4. Lead Optimization
      • 7.2.4. Global Drug Discovery Services by: Therapeutic Area (Value)
        • 7.2.4.1. Oncology
        • 7.2.4.2. Neurology
        • 7.2.4.3. Infectious and Immune System Diseases
        • 7.2.4.4. Digestive System Diseases
        • 7.2.4.5. Cardiovascular Diseases
        • 7.2.4.6. Other Therapeutic Areas
      • 7.2.5. Global Drug Discovery Services Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Drug Discovery Services (Volume)
      • 7.3.1. Global Drug Discovery Services by: Type (Volume)
        • 7.3.1.1. Medicinal Chemistry Services
        • 7.3.1.2. Biology Services
        • 7.3.1.3. Drug Metabolism and Pharmacokinetics (DMPK)
        • 7.3.1.4. Market, by Drug Type
        • 7.3.1.5. Small- molecule Drugs
        • 7.3.1.6. Biologic Drugs
      • 7.3.2. Global Drug Discovery Services by: Application (Volume)
        • 7.3.2.1. New Drugs Discoveries
        • 7.3.2.2. Research Studies
        • 7.3.2.3. Clinical Trials
      • 7.3.3. Global Drug Discovery Services by: Process (Volume)
        • 7.3.3.1. Target Selection
        • 7.3.3.2. Target Validation
        • 7.3.3.3. Hit-To-Lead Identification
        • 7.3.3.4. Lead Optimization
      • 7.3.4. Global Drug Discovery Services by: Therapeutic Area (Volume)
        • 7.3.4.1. Oncology
        • 7.3.4.2. Neurology
        • 7.3.4.3. Infectious and Immune System Diseases
        • 7.3.4.4. Digestive System Diseases
        • 7.3.4.5. Cardiovascular Diseases
        • 7.3.4.6. Other Therapeutic Areas
      • 7.3.5. Global Drug Discovery Services Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Drug Discovery Services (Price)
      • 7.4.1. Global Drug Discovery Services by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Discovery Services: by Type(USD Million)
  • Table 2. Drug Discovery Services Medicinal Chemistry Services , by Region USD Million (2017-2022)
  • Table 3. Drug Discovery Services Biology Services , by Region USD Million (2017-2022)
  • Table 4. Drug Discovery Services Drug Metabolism and Pharmacokinetics (DMPK) , by Region USD Million (2017-2022)
  • Table 5. Drug Discovery Services Market, by Drug Type , by Region USD Million (2017-2022)
  • Table 6. Drug Discovery Services Small- molecule Drugs , by Region USD Million (2017-2022)
  • Table 7. Drug Discovery Services Biologic Drugs , by Region USD Million (2017-2022)
  • Table 8. Drug Discovery Services: by Application(USD Million)
  • Table 9. Drug Discovery Services New Drugs Discoveries , by Region USD Million (2017-2022)
  • Table 10. Drug Discovery Services Research Studies , by Region USD Million (2017-2022)
  • Table 11. Drug Discovery Services Clinical Trials , by Region USD Million (2017-2022)
  • Table 12. Drug Discovery Services: by Process(USD Million)
  • Table 13. Drug Discovery Services Target Selection , by Region USD Million (2017-2022)
  • Table 14. Drug Discovery Services Target Validation , by Region USD Million (2017-2022)
  • Table 15. Drug Discovery Services Hit-To-Lead Identification , by Region USD Million (2017-2022)
  • Table 16. Drug Discovery Services Lead Optimization , by Region USD Million (2017-2022)
  • Table 17. Drug Discovery Services: by Therapeutic Area(USD Million)
  • Table 18. Drug Discovery Services Oncology , by Region USD Million (2017-2022)
  • Table 19. Drug Discovery Services Neurology , by Region USD Million (2017-2022)
  • Table 20. Drug Discovery Services Infectious and Immune System Diseases , by Region USD Million (2017-2022)
  • Table 21. Drug Discovery Services Digestive System Diseases , by Region USD Million (2017-2022)
  • Table 22. Drug Discovery Services Cardiovascular Diseases , by Region USD Million (2017-2022)
  • Table 23. Drug Discovery Services Other Therapeutic Areas , by Region USD Million (2017-2022)
  • Table 24. South America Drug Discovery Services, by Country USD Million (2017-2022)
  • Table 25. South America Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 26. South America Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 27. South America Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 28. South America Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 29. South America Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 30. Brazil Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 31. Brazil Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 32. Brazil Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 33. Brazil Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 34. Brazil Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 35. Argentina Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 36. Argentina Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 37. Argentina Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 38. Argentina Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 39. Argentina Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 40. Rest of South America Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 41. Rest of South America Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 42. Rest of South America Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 43. Rest of South America Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 44. Rest of South America Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 45. Asia Pacific Drug Discovery Services, by Country USD Million (2017-2022)
  • Table 46. Asia Pacific Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 47. Asia Pacific Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 48. Asia Pacific Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 49. Asia Pacific Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 50. Asia Pacific Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 51. China Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 52. China Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 53. China Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 54. China Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 55. China Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 56. Japan Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 57. Japan Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 58. Japan Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 59. Japan Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 60. Japan Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 61. India Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 62. India Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 63. India Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 64. India Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 65. India Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 66. South Korea Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 67. South Korea Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 68. South Korea Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 69. South Korea Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 70. South Korea Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 71. Taiwan Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 72. Taiwan Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 73. Taiwan Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 74. Taiwan Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 75. Taiwan Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 76. Australia Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 77. Australia Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 78. Australia Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 79. Australia Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 80. Australia Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 84. Rest of Asia-Pacific Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 85. Rest of Asia-Pacific Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 86. Europe Drug Discovery Services, by Country USD Million (2017-2022)
  • Table 87. Europe Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 88. Europe Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 89. Europe Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 90. Europe Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 91. Europe Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 92. Germany Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 93. Germany Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 94. Germany Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 95. Germany Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 96. Germany Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 97. France Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 98. France Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 99. France Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 100. France Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 101. France Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 102. Italy Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 103. Italy Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 104. Italy Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 105. Italy Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 106. Italy Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 107. United Kingdom Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 108. United Kingdom Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 109. United Kingdom Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 110. United Kingdom Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 111. United Kingdom Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 112. Netherlands Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 113. Netherlands Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 114. Netherlands Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 115. Netherlands Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 116. Netherlands Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 117. Rest of Europe Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 118. Rest of Europe Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 119. Rest of Europe Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 120. Rest of Europe Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 121. Rest of Europe Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 122. MEA Drug Discovery Services, by Country USD Million (2017-2022)
  • Table 123. MEA Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 124. MEA Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 125. MEA Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 126. MEA Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 127. MEA Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 128. Middle East Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 129. Middle East Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 130. Middle East Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 131. Middle East Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 132. Middle East Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 133. Africa Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 134. Africa Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 135. Africa Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 136. Africa Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 137. Africa Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 138. North America Drug Discovery Services, by Country USD Million (2017-2022)
  • Table 139. North America Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 140. North America Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 141. North America Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 142. North America Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 143. North America Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 144. United States Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 145. United States Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 146. United States Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 147. United States Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 148. United States Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 149. Canada Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 150. Canada Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 151. Canada Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 152. Canada Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 153. Canada Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 154. Mexico Drug Discovery Services, by Type USD Million (2017-2022)
  • Table 155. Mexico Drug Discovery Services, by Application USD Million (2017-2022)
  • Table 156. Mexico Drug Discovery Services, by Company USD Million (2017-2022)
  • Table 157. Mexico Drug Discovery Services, by Process USD Million (2017-2022)
  • Table 158. Mexico Drug Discovery Services, by Therapeutic Area USD Million (2017-2022)
  • Table 159. Drug Discovery Services Sales: by Type(K Units)
  • Table 160. Drug Discovery Services Sales Medicinal Chemistry Services , by Region K Units (2017-2022)
  • Table 161. Drug Discovery Services Sales Biology Services , by Region K Units (2017-2022)
  • Table 162. Drug Discovery Services Sales Drug Metabolism and Pharmacokinetics (DMPK) , by Region K Units (2017-2022)
  • Table 163. Drug Discovery Services Sales Market, by Drug Type , by Region K Units (2017-2022)
  • Table 164. Drug Discovery Services Sales Small- molecule Drugs , by Region K Units (2017-2022)
  • Table 165. Drug Discovery Services Sales Biologic Drugs , by Region K Units (2017-2022)
  • Table 166. Drug Discovery Services Sales: by Application(K Units)
  • Table 167. Drug Discovery Services Sales New Drugs Discoveries , by Region K Units (2017-2022)
  • Table 168. Drug Discovery Services Sales Research Studies , by Region K Units (2017-2022)
  • Table 169. Drug Discovery Services Sales Clinical Trials , by Region K Units (2017-2022)
  • Table 170. Drug Discovery Services Sales: by Process(K Units)
  • Table 171. Drug Discovery Services Sales Target Selection , by Region K Units (2017-2022)
  • Table 172. Drug Discovery Services Sales Target Validation , by Region K Units (2017-2022)
  • Table 173. Drug Discovery Services Sales Hit-To-Lead Identification , by Region K Units (2017-2022)
  • Table 174. Drug Discovery Services Sales Lead Optimization , by Region K Units (2017-2022)
  • Table 175. Drug Discovery Services Sales: by Therapeutic Area(K Units)
  • Table 176. Drug Discovery Services Sales Oncology , by Region K Units (2017-2022)
  • Table 177. Drug Discovery Services Sales Neurology , by Region K Units (2017-2022)
  • Table 178. Drug Discovery Services Sales Infectious and Immune System Diseases , by Region K Units (2017-2022)
  • Table 179. Drug Discovery Services Sales Digestive System Diseases , by Region K Units (2017-2022)
  • Table 180. Drug Discovery Services Sales Cardiovascular Diseases , by Region K Units (2017-2022)
  • Table 181. Drug Discovery Services Sales Other Therapeutic Areas , by Region K Units (2017-2022)
  • Table 182. South America Drug Discovery Services Sales, by Country K Units (2017-2022)
  • Table 183. South America Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 184. South America Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 185. South America Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 186. South America Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 187. South America Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 188. Brazil Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 189. Brazil Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 190. Brazil Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 191. Brazil Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 192. Brazil Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 193. Argentina Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 194. Argentina Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 195. Argentina Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 196. Argentina Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 197. Argentina Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 198. Rest of South America Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 199. Rest of South America Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 200. Rest of South America Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 201. Rest of South America Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 202. Rest of South America Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 203. Asia Pacific Drug Discovery Services Sales, by Country K Units (2017-2022)
  • Table 204. Asia Pacific Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 205. Asia Pacific Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 206. Asia Pacific Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 207. Asia Pacific Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 208. Asia Pacific Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 209. China Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 210. China Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 211. China Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 212. China Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 213. China Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 214. Japan Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 215. Japan Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 216. Japan Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 217. Japan Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 218. Japan Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 219. India Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 220. India Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 221. India Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 222. India Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 223. India Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 224. South Korea Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 225. South Korea Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 226. South Korea Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 227. South Korea Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 228. South Korea Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 229. Taiwan Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 230. Taiwan Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 231. Taiwan Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 232. Taiwan Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 233. Taiwan Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 234. Australia Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 235. Australia Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 236. Australia Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 237. Australia Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 238. Australia Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 239. Rest of Asia-Pacific Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 240. Rest of Asia-Pacific Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 241. Rest of Asia-Pacific Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 242. Rest of Asia-Pacific Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 243. Rest of Asia-Pacific Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 244. Europe Drug Discovery Services Sales, by Country K Units (2017-2022)
  • Table 245. Europe Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 246. Europe Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 247. Europe Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 248. Europe Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 249. Europe Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 250. Germany Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 251. Germany Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 252. Germany Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 253. Germany Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 254. Germany Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 255. France Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 256. France Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 257. France Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 258. France Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 259. France Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 260. Italy Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 261. Italy Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 262. Italy Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 263. Italy Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 264. Italy Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 265. United Kingdom Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 266. United Kingdom Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 267. United Kingdom Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 268. United Kingdom Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 269. United Kingdom Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 270. Netherlands Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 271. Netherlands Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 272. Netherlands Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 273. Netherlands Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 274. Netherlands Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 275. Rest of Europe Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 276. Rest of Europe Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 277. Rest of Europe Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 278. Rest of Europe Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 279. Rest of Europe Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 280. MEA Drug Discovery Services Sales, by Country K Units (2017-2022)
  • Table 281. MEA Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 282. MEA Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 283. MEA Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 284. MEA Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 285. MEA Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 286. Middle East Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 287. Middle East Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 288. Middle East Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 289. Middle East Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 290. Middle East Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 291. Africa Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 292. Africa Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 293. Africa Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 294. Africa Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 295. Africa Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 296. North America Drug Discovery Services Sales, by Country K Units (2017-2022)
  • Table 297. North America Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 298. North America Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 299. North America Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 300. North America Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 301. North America Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 302. United States Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 303. United States Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 304. United States Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 305. United States Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 306. United States Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 307. Canada Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 308. Canada Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 309. Canada Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 310. Canada Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 311. Canada Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 312. Mexico Drug Discovery Services Sales, by Type K Units (2017-2022)
  • Table 313. Mexico Drug Discovery Services Sales, by Application K Units (2017-2022)
  • Table 314. Mexico Drug Discovery Services Sales, by Company K Units (2017-2022)
  • Table 315. Mexico Drug Discovery Services Sales, by Process K Units (2017-2022)
  • Table 316. Mexico Drug Discovery Services Sales, by Therapeutic Area K Units (2017-2022)
  • Table 317. Drug Discovery Services: by Type(USD/Units)
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Company Basic Information, Sales Area and Its Competitors
  • Table 331. Drug Discovery Services: by Type(USD Million)
  • Table 332. Drug Discovery Services Medicinal Chemistry Services , by Region USD Million (2023-2028)
  • Table 333. Drug Discovery Services Biology Services , by Region USD Million (2023-2028)
  • Table 334. Drug Discovery Services Drug Metabolism and Pharmacokinetics (DMPK) , by Region USD Million (2023-2028)
  • Table 335. Drug Discovery Services Market, by Drug Type , by Region USD Million (2023-2028)
  • Table 336. Drug Discovery Services Small- molecule Drugs , by Region USD Million (2023-2028)
  • Table 337. Drug Discovery Services Biologic Drugs , by Region USD Million (2023-2028)
  • Table 338. Drug Discovery Services: by Application(USD Million)
  • Table 339. Drug Discovery Services New Drugs Discoveries , by Region USD Million (2023-2028)
  • Table 340. Drug Discovery Services Research Studies , by Region USD Million (2023-2028)
  • Table 341. Drug Discovery Services Clinical Trials , by Region USD Million (2023-2028)
  • Table 342. Drug Discovery Services: by Process(USD Million)
  • Table 343. Drug Discovery Services Target Selection , by Region USD Million (2023-2028)
  • Table 344. Drug Discovery Services Target Validation , by Region USD Million (2023-2028)
  • Table 345. Drug Discovery Services Hit-To-Lead Identification , by Region USD Million (2023-2028)
  • Table 346. Drug Discovery Services Lead Optimization , by Region USD Million (2023-2028)
  • Table 347. Drug Discovery Services: by Therapeutic Area(USD Million)
  • Table 348. Drug Discovery Services Oncology , by Region USD Million (2023-2028)
  • Table 349. Drug Discovery Services Neurology , by Region USD Million (2023-2028)
  • Table 350. Drug Discovery Services Infectious and Immune System Diseases , by Region USD Million (2023-2028)
  • Table 351. Drug Discovery Services Digestive System Diseases , by Region USD Million (2023-2028)
  • Table 352. Drug Discovery Services Cardiovascular Diseases , by Region USD Million (2023-2028)
  • Table 353. Drug Discovery Services Other Therapeutic Areas , by Region USD Million (2023-2028)
  • Table 354. South America Drug Discovery Services, by Country USD Million (2023-2028)
  • Table 355. South America Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 356. South America Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 357. South America Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 358. South America Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 359. South America Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 360. Brazil Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 361. Brazil Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 362. Brazil Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 363. Brazil Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 364. Brazil Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 365. Argentina Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 366. Argentina Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 367. Argentina Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 368. Argentina Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 369. Argentina Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 370. Rest of South America Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 371. Rest of South America Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 372. Rest of South America Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 373. Rest of South America Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 374. Rest of South America Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 375. Asia Pacific Drug Discovery Services, by Country USD Million (2023-2028)
  • Table 376. Asia Pacific Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 377. Asia Pacific Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 378. Asia Pacific Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 379. Asia Pacific Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 380. Asia Pacific Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 381. China Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 382. China Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 383. China Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 384. China Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 385. China Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 386. Japan Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 387. Japan Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 388. Japan Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 389. Japan Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 390. Japan Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 391. India Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 392. India Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 393. India Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 394. India Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 395. India Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 396. South Korea Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 397. South Korea Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 398. South Korea Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 399. South Korea Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 400. South Korea Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 401. Taiwan Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 402. Taiwan Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 403. Taiwan Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 404. Taiwan Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 405. Taiwan Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 406. Australia Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 407. Australia Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 408. Australia Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 409. Australia Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 410. Australia Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 411. Rest of Asia-Pacific Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 412. Rest of Asia-Pacific Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 413. Rest of Asia-Pacific Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 414. Rest of Asia-Pacific Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 415. Rest of Asia-Pacific Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 416. Europe Drug Discovery Services, by Country USD Million (2023-2028)
  • Table 417. Europe Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 418. Europe Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 419. Europe Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 420. Europe Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 421. Europe Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 422. Germany Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 423. Germany Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 424. Germany Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 425. Germany Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 426. Germany Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 427. France Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 428. France Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 429. France Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 430. France Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 431. France Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 432. Italy Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 433. Italy Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 434. Italy Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 435. Italy Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 436. Italy Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 437. United Kingdom Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 438. United Kingdom Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 439. United Kingdom Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 440. United Kingdom Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 441. United Kingdom Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 442. Netherlands Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 443. Netherlands Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 444. Netherlands Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 445. Netherlands Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 446. Netherlands Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 447. Rest of Europe Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 448. Rest of Europe Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 449. Rest of Europe Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 450. Rest of Europe Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 451. Rest of Europe Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 452. MEA Drug Discovery Services, by Country USD Million (2023-2028)
  • Table 453. MEA Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 454. MEA Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 455. MEA Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 456. MEA Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 457. MEA Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 458. Middle East Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 459. Middle East Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 460. Middle East Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 461. Middle East Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 462. Middle East Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 463. Africa Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 464. Africa Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 465. Africa Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 466. Africa Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 467. Africa Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 468. North America Drug Discovery Services, by Country USD Million (2023-2028)
  • Table 469. North America Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 470. North America Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 471. North America Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 472. North America Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 473. North America Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 474. United States Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 475. United States Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 476. United States Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 477. United States Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 478. United States Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 479. Canada Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 480. Canada Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 481. Canada Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 482. Canada Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 483. Canada Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 484. Mexico Drug Discovery Services, by Type USD Million (2023-2028)
  • Table 485. Mexico Drug Discovery Services, by Application USD Million (2023-2028)
  • Table 486. Mexico Drug Discovery Services, by Company USD Million (2023-2028)
  • Table 487. Mexico Drug Discovery Services, by Process USD Million (2023-2028)
  • Table 488. Mexico Drug Discovery Services, by Therapeutic Area USD Million (2023-2028)
  • Table 489. Drug Discovery Services Sales: by Type(K Units)
  • Table 490. Drug Discovery Services Sales Medicinal Chemistry Services , by Region K Units (2023-2028)
  • Table 491. Drug Discovery Services Sales Biology Services , by Region K Units (2023-2028)
  • Table 492. Drug Discovery Services Sales Drug Metabolism and Pharmacokinetics (DMPK) , by Region K Units (2023-2028)
  • Table 493. Drug Discovery Services Sales Market, by Drug Type , by Region K Units (2023-2028)
  • Table 494. Drug Discovery Services Sales Small- molecule Drugs , by Region K Units (2023-2028)
  • Table 495. Drug Discovery Services Sales Biologic Drugs , by Region K Units (2023-2028)
  • Table 496. Drug Discovery Services Sales: by Application(K Units)
  • Table 497. Drug Discovery Services Sales New Drugs Discoveries , by Region K Units (2023-2028)
  • Table 498. Drug Discovery Services Sales Research Studies , by Region K Units (2023-2028)
  • Table 499. Drug Discovery Services Sales Clinical Trials , by Region K Units (2023-2028)
  • Table 500. Drug Discovery Services Sales: by Process(K Units)
  • Table 501. Drug Discovery Services Sales Target Selection , by Region K Units (2023-2028)
  • Table 502. Drug Discovery Services Sales Target Validation , by Region K Units (2023-2028)
  • Table 503. Drug Discovery Services Sales Hit-To-Lead Identification , by Region K Units (2023-2028)
  • Table 504. Drug Discovery Services Sales Lead Optimization , by Region K Units (2023-2028)
  • Table 505. Drug Discovery Services Sales: by Therapeutic Area(K Units)
  • Table 506. Drug Discovery Services Sales Oncology , by Region K Units (2023-2028)
  • Table 507. Drug Discovery Services Sales Neurology , by Region K Units (2023-2028)
  • Table 508. Drug Discovery Services Sales Infectious and Immune System Diseases , by Region K Units (2023-2028)
  • Table 509. Drug Discovery Services Sales Digestive System Diseases , by Region K Units (2023-2028)
  • Table 510. Drug Discovery Services Sales Cardiovascular Diseases , by Region K Units (2023-2028)
  • Table 511. Drug Discovery Services Sales Other Therapeutic Areas , by Region K Units (2023-2028)
  • Table 512. South America Drug Discovery Services Sales, by Country K Units (2023-2028)
  • Table 513. South America Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 514. South America Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 515. South America Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 516. South America Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 517. South America Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 518. Brazil Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 519. Brazil Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 520. Brazil Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 521. Brazil Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 522. Brazil Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 523. Argentina Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 524. Argentina Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 525. Argentina Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 526. Argentina Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 527. Argentina Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 528. Rest of South America Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 529. Rest of South America Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 530. Rest of South America Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 531. Rest of South America Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 532. Rest of South America Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 533. Asia Pacific Drug Discovery Services Sales, by Country K Units (2023-2028)
  • Table 534. Asia Pacific Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 535. Asia Pacific Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 536. Asia Pacific Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 537. Asia Pacific Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 538. Asia Pacific Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 539. China Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 540. China Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 541. China Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 542. China Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 543. China Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 544. Japan Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 545. Japan Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 546. Japan Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 547. Japan Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 548. Japan Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 549. India Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 550. India Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 551. India Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 552. India Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 553. India Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 554. South Korea Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 555. South Korea Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 556. South Korea Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 557. South Korea Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 558. South Korea Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 559. Taiwan Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 560. Taiwan Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 561. Taiwan Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 562. Taiwan Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 563. Taiwan Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 564. Australia Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 565. Australia Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 566. Australia Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 567. Australia Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 568. Australia Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 569. Rest of Asia-Pacific Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 570. Rest of Asia-Pacific Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 571. Rest of Asia-Pacific Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 572. Rest of Asia-Pacific Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 573. Rest of Asia-Pacific Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 574. Europe Drug Discovery Services Sales, by Country K Units (2023-2028)
  • Table 575. Europe Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 576. Europe Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 577. Europe Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 578. Europe Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 579. Europe Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 580. Germany Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 581. Germany Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 582. Germany Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 583. Germany Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 584. Germany Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 585. France Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 586. France Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 587. France Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 588. France Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 589. France Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 590. Italy Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 591. Italy Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 592. Italy Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 593. Italy Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 594. Italy Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 595. United Kingdom Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 596. United Kingdom Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 597. United Kingdom Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 598. United Kingdom Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 599. United Kingdom Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 600. Netherlands Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 601. Netherlands Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 602. Netherlands Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 603. Netherlands Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 604. Netherlands Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 605. Rest of Europe Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 606. Rest of Europe Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 607. Rest of Europe Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 608. Rest of Europe Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 609. Rest of Europe Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 610. MEA Drug Discovery Services Sales, by Country K Units (2023-2028)
  • Table 611. MEA Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 612. MEA Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 613. MEA Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 614. MEA Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 615. MEA Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 616. Middle East Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 617. Middle East Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 618. Middle East Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 619. Middle East Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 620. Middle East Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 621. Africa Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 622. Africa Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 623. Africa Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 624. Africa Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 625. Africa Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 626. North America Drug Discovery Services Sales, by Country K Units (2023-2028)
  • Table 627. North America Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 628. North America Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 629. North America Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 630. North America Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 631. North America Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 632. United States Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 633. United States Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 634. United States Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 635. United States Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 636. United States Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 637. Canada Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 638. Canada Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 639. Canada Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 640. Canada Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 641. Canada Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 642. Mexico Drug Discovery Services Sales, by Type K Units (2023-2028)
  • Table 643. Mexico Drug Discovery Services Sales, by Application K Units (2023-2028)
  • Table 644. Mexico Drug Discovery Services Sales, by Company K Units (2023-2028)
  • Table 645. Mexico Drug Discovery Services Sales, by Process K Units (2023-2028)
  • Table 646. Mexico Drug Discovery Services Sales, by Therapeutic Area K Units (2023-2028)
  • Table 647. Drug Discovery Services: by Type(USD/Units)
  • Table 648. Research Programs/Design for This Report
  • Table 649. Key Data Information from Secondary Sources
  • Table 650. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Discovery Services: by Type USD Million (2017-2022)
  • Figure 5. Global Drug Discovery Services: by Application USD Million (2017-2022)
  • Figure 6. Global Drug Discovery Services: by Process USD Million (2017-2022)
  • Figure 7. Global Drug Discovery Services: by Therapeutic Area USD Million (2017-2022)
  • Figure 8. South America Drug Discovery Services Share (%), by Country
  • Figure 9. Asia Pacific Drug Discovery Services Share (%), by Country
  • Figure 10. Europe Drug Discovery Services Share (%), by Country
  • Figure 11. MEA Drug Discovery Services Share (%), by Country
  • Figure 12. North America Drug Discovery Services Share (%), by Country
  • Figure 13. Global Drug Discovery Services: by Type K Units (2017-2022)
  • Figure 14. Global Drug Discovery Services: by Application K Units (2017-2022)
  • Figure 15. Global Drug Discovery Services: by Process K Units (2017-2022)
  • Figure 16. Global Drug Discovery Services: by Therapeutic Area K Units (2017-2022)
  • Figure 17. South America Drug Discovery Services Share (%), by Country
  • Figure 18. Asia Pacific Drug Discovery Services Share (%), by Country
  • Figure 19. Europe Drug Discovery Services Share (%), by Country
  • Figure 20. MEA Drug Discovery Services Share (%), by Country
  • Figure 21. North America Drug Discovery Services Share (%), by Country
  • Figure 22. Global Drug Discovery Services: by Type USD/Units (2017-2022)
  • Figure 23. Global Drug Discovery Services share by Players 2022 (%)
  • Figure 24. Global Drug Discovery Services share by Players (Top 3) 2022(%)
  • Figure 25. Global Drug Discovery Services share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 29. Albany Molecular Research (United States) Revenue, Net Income and Gross profit
  • Figure 30. Albany Molecular Research (United States) Revenue: by Geography 2022
  • Figure 31. Charles River Laboratories International (United States) Revenue, Net Income and Gross profit
  • Figure 32. Charles River Laboratories International (United States) Revenue: by Geography 2022
  • Figure 33. Evotec SE (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Evotec SE (Germany) Revenue: by Geography 2022
  • Figure 35. Eurofins Scientific (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 36. Eurofins Scientific (Luxembourg) Revenue: by Geography 2022
  • Figure 37. WuXi AppTec (China) Revenue, Net Income and Gross profit
  • Figure 38. WuXi AppTec (China) Revenue: by Geography 2022
  • Figure 39. GenScript Biotech Corporation (China) Revenue, Net Income and Gross profit
  • Figure 40. GenScript Biotech Corporation (China) Revenue: by Geography 2022
  • Figure 41. Jubilant Life Sciences (India) Revenue, Net Income and Gross profit
  • Figure 42. Jubilant Life Sciences (India) Revenue: by Geography 2022
  • Figure 43. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 44. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2022
  • Figure 45. Piramal Enterprises (India) Revenue, Net Income and Gross profit
  • Figure 46. Piramal Enterprises (India) Revenue: by Geography 2022
  • Figure 47. Viva Biotech (China) Revenue, Net Income and Gross profit
  • Figure 48. Viva Biotech (China) Revenue: by Geography 2022
  • Figure 49. Domainex (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 50. Domainex (United Kingdom) Revenue: by Geography 2022
  • Figure 51. Shanghai Medicilon(China) Revenue, Net Income and Gross profit
  • Figure 52. Shanghai Medicilon(China) Revenue: by Geography 2022
  • Figure 53. Global Drug Discovery Services: by Type USD Million (2023-2028)
  • Figure 54. Global Drug Discovery Services: by Application USD Million (2023-2028)
  • Figure 55. Global Drug Discovery Services: by Process USD Million (2023-2028)
  • Figure 56. Global Drug Discovery Services: by Therapeutic Area USD Million (2023-2028)
  • Figure 57. South America Drug Discovery Services Share (%), by Country
  • Figure 58. Asia Pacific Drug Discovery Services Share (%), by Country
  • Figure 59. Europe Drug Discovery Services Share (%), by Country
  • Figure 60. MEA Drug Discovery Services Share (%), by Country
  • Figure 61. North America Drug Discovery Services Share (%), by Country
  • Figure 62. Global Drug Discovery Services: by Type K Units (2023-2028)
  • Figure 63. Global Drug Discovery Services: by Application K Units (2023-2028)
  • Figure 64. Global Drug Discovery Services: by Process K Units (2023-2028)
  • Figure 65. Global Drug Discovery Services: by Therapeutic Area K Units (2023-2028)
  • Figure 66. South America Drug Discovery Services Share (%), by Country
  • Figure 67. Asia Pacific Drug Discovery Services Share (%), by Country
  • Figure 68. Europe Drug Discovery Services Share (%), by Country
  • Figure 69. MEA Drug Discovery Services Share (%), by Country
  • Figure 70. North America Drug Discovery Services Share (%), by Country
  • Figure 71. Global Drug Discovery Services: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Albany Molecular Research (United States)
  • Charles River Laboratories International (United States)
  • Evotec SE (Germany)
  • Eurofins Scientific (Luxembourg)
  • WuXi AppTec (China)
  • GenScript Biotech Corporation (China)
  • Jubilant Life Sciences (India)
  • Laboratory Corporation of America Holdings (United States)
  • Piramal Enterprises (India)
  • Viva Biotech (China)
  • Domainex (United Kingdom)
  • Shanghai Medicilon(China)
Additional players considered in the study are as follows:
TCG Lifesciences Pvt. Limited (India) , Frontage Holdings (United States) , Pharmaceutical Product Development, LLC (United States) , Syngene International (India) , ChemPartner (China) , Aurigene Discovery Technologies Limited (Dr. Reddy’s, Laboratories) (India), , Selvita S.A. (Poland)
Select User Access Type

Key Highlights of Report


Dec 2023 250 Pages 96 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Discovery Services Quantitative research analysis
Global Drug Discovery Services Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Drug Discovery Services Market are Thermo Fisher Scientific (United States), Albany Molecular Research (United States), Charles River Laboratories International (United States), Evotec SE (Germany), Eurofins Scientific (Luxembourg), WuXi AppTec (China), GenScript Biotech Corporation (China), Jubilant Life Sciences (India), Laboratory Corporation of America Holdings (United States), Piramal Enterprises (India), Viva Biotech (China), Domainex (United Kingdom) and Shanghai Medicilon(China) etc.
New Drugs Discoveries segment in Global market to hold robust market share owing to "Growing Incurable Disorders ".
AMA Research predicts that Asia Pacific Players will contribute to the maximum growth of Global Drug Discovery Services market throughout the forecasted period.

Know More About Global Drug Discovery Services Report?

Have a Query? Click Here

Other Related Reports

Gene Editing Comprehensive Study by Type (Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nucleases (TALEN), Zinc-finger Nucleases (ZFNs), Homing Endo...
$ 3750
Sulfasalazine Tablets Comprehensive Study by Type (Enteric Sugar Coated Tablet, Film-Coated Tablet, Other), Application (Fever, Arthritis, Stomach pain, Diarrhea, Rectal bleeding, Others), Shape (Ova...
$ 3350
Biopharmaceutical Comprehensive Study by Type (Monoclonal Antibodies, Erythropoietin (EPO), Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferon...
$ 3750
Human Albumin Comprehensive Study by Type (Human Serum Albumin, Recombinant Serum Albumin), Application (Drug Delivery, Therapeutics, Culture Media, Vaccine Ingredient, Others), End-User (Pharmaceuti...
$ 3450
Pyrolysis Gasoline Comprehensive Study by Type (Raw Pyrolysis Gasoline, Hydrogenated Pyrolysis Gasoline), Application (Aromatics Extraction, Refinery Feedstock, Fractionation for Benzene, Others), En...
$ 3450
Pharmaceutical Gelatin Comprehensive Study by Application (Hard Capsules, Soft Capsules, Micro-encapsulation, Coating for Tablets, Absorbable Hemostat), Function (Stabilizers, Thickeners, Gelling Age...
$ 3450